Delivery Order 75F40122D00007-75F40122F19001
- Not listed
- The federal contract award is for PROPHARMA GROUP, LLC, a Research Consulting Organization (RCO) doing business as Acadeus. The contract, valued at $150,000.00, was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency, under a Blanket Purchase Agreement (BPA) Call contract type. The award is for expert consulting services to support the agency's reorganization, quality unit operations, and investigational drug management. Propharma Group LLC is the...
- This is a firm fixed-price contract awarded by the National Institutes of Health (NIH) Clinical Center to Propharma Group LLC, doing business as Acadeus, with a ceiling value of $321,950.00. The contract is for the development of operational plans and procedures for the Investigational Drug Control Unit (IDCU) and Investigational Drug Operations Unit (IDOU) to remediate audit observations related to the handling, distribution, storage, and management of investigational drugs. The contract was...
- This is a firm fixed price contract awarded by the National Institutes of Health (NIH) Clinical Center to Propharma Group LLC, doing business as Acadeus, for expert consulting services related to the NIH's aseptic processing facilities. The contract has a ceiling value of $700,000.00 and an ultimate completion date of March 28, 2023. It was awarded on March 29, 2022 under the NIH's Blanket Purchase Agreement (BPA) for expert consultant services, which has a total value of $15 million and is...
- Propharma Group LLC, doing business as Acadeus, was awarded a Blanket Purchase Agreement (BPA) call contract by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency. The contract has a ceiling value of $600,000.00 and runs through March 31, 2023. It is a firm fixed price contract issued against the Multiple Award Schedule (MAS) contract vehicle. Propharma Group provides expert consulting services to the NIH, including support for quality unit reorganization,...
- The National Institutes of Health (NIH) Clinical Center awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $850,000.00 to Propharma Group LLC, doing business as Acadeus, to provide expert consultant services. This contract was issued under the NIH's Multiple Award Schedule (MAS) vehicle, a government-wide acquisition contract managed by the General Services Administration (GSA). Propharma Group is a for-profit organization and Subchapter S Corporation that specializes...
- This is a contract award to Propharma Group LLC, doing business as Acadeus, by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency. The $152,000 firm fixed price contract is a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract vehicle. The contract provides expert consulting services to the NIH Clinical Center, including support for quality unit reorganization, investigational drug management, and general project support....
- This federal contract award to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, is a firm fixed-price delivery order contract awarded by the Northeast Area of a civilian federal agency. The contract, which has a ceiling value of $165,447.00, is for a variety of laboratory testing and analytical services, including stability testing, potency and safety assays, polyclonal antibody production, and pharmacokinetics testing for various...
- This is a definitive contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $641,490.62, was awarded to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, a for-profit organization. The contract is for regulatory and support services related to the development of investigational new drugs. It is a firm...
- This is a firm fixed-price delivery order contract awarded by the Northeast Area division of a civilian federal agency to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings. The $94,239.14 contract is for the provision of laboratory testing and analytical services, including stability testing, potency and safety assays, polyclonal antibody production, pharmacokinetics testing, compositional analysis, and other services to support the work of...
- This is a new task order awarded under an existing Indefinite Delivery Indefinite Quantity (IDIQ) contract (HHSF223201610004I) with the Department of Health and Human Services Food and Drug Administration (FDA). The task order, valued at $2,470,791.00, is for a Pharmacokinetic (PK) study of opioid drug products following oral ingestion of chewed products. The study falls under the FDA's In Vivo Study of Generic Drug Products in Human Subjects program. The contract is a Firm Fixed Price...
- 75F40122D00007Indefinite Delivery Contract
- 75F40122D00007-75F40122F19001Delivery Order
This federal contract award, valued at $7,736,500.00, was issued by the Food and Drug Administration (FDA) to Propharma Group LLC, doing business as Acadeus. The contract is for the "Review of Laboratory-Developed Tests (LDTs) and In Vitro Diagnostics (IVDs) Support to #1" and has a period of performance ending on September 6, 2024. The contract is a Delivery Order with a Labor Hours pricing type and does not have a set-aside designation. Propharma Group LLC is a for-profit organization and Subchapter S Corporation that specializes in providing expert consulting services to federal agencies, particularly in the healthcare and medical research sectors. The company has established Indefinite Delivery Vehicles (IDVs) with the FDA and the National Institutes of Health (NIH) Clinical Center, allowing it to deliver a range of services including quality assurance, operational planning, regulatory compliance, pharmacovigilance, and research support. Propharma Group has also participated as a subrecipient on federal research grants, further demonstrating its expertise in contributing to scientific advancements and medical research projects funded by the government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 8/16/24 | |
| P00002 | Other Administrative Action | $0 | 1/12/24 | |
| P00001 | Other Administrative Action | $3.9m | 3/1/23 | |
| Not listed | Not listed | $3.9m | 3/2/22 |